INHALE-PD · Real-world Patient Experiences With Inbrija®
Recruitment opened
Merz Therapeutics GmbHNot specified NCT07797790 Registry history of NCT07797790 on ClinicalTrials.gov (opens the registry)
3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
Recruitment opened
Merz Therapeutics GmbHNot specified NCT07797790 Registry history of NCT07797790 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Merz Therapeutics GmbHPhase 3 NCT07018700 Registry history of NCT07018700 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion moved earlier from Oct 2027 to Mar 2027; Study completion moved earlier from Mar 2028 to Sep 2027
Merz Therapeutics GmbHPhase 3 NCT07018713 Registry history of NCT07018713 on ClinicalTrials.gov (opens the registry)
| Phase 3 | 2 |
Migraine (2) · Parkinson's Disease (1)